Literature DB >> 8115637

Mediastinal invasion by bronchogenic carcinoma: CT signs.

S J Herman1, T L Winton, G L Weisbrod, M J Towers, S J Mentzer.   

Abstract

PURPOSE: To determine the accuracy of computed tomographic (CT) signs in assessment of direct mediastinal invasion by primary bronchogenic carcinoma.
MATERIALS AND METHODS: In 90 patients with primary bronchogenic carcinoma who underwent CT with thoracic surgical staging and thoracotomy, the pathologic and CT findings in 14 mediastinal structures were compared retrospectively. The degree of contact of the primary tumor with each structure and whether the structure was distorted or contained intraluminal tumor were recorded. A total of 785 mediastinal structures (25 with tumor invasion) were analyzed.
RESULTS: When greater than 90 degrees of contact was considered a positive CT finding, the sensitivity of CT was 40% (10 of 25 structures); specificity, 99% (752 of 760 structures); and positive and negative predictive values, 56% and 98%. All structures with > 180 degrees of contact had pathologic involvement, but only 11 of 17 distorted structures (65%) and five of seven structures with intraluminal tumor (71%) were involved.
CONCLUSION: CT is insensitive in detection of mediastinal invasion by primary bronchogenic carcinoma. The positive predictive value may be higher, depending on the criteria used.

Entities:  

Mesh:

Year:  1994        PMID: 8115637     DOI: 10.1148/radiology.190.3.8115637

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  11 in total

1.  Recommendations for radiological diagnosis and assessment of treatment response in lung cancer: a national consensus statement by the Spanish Society of Medical Radiology and the Spanish Society of Medical Oncology.

Authors:  J de Castro; M Cobo; D Isla; J Puente; N Reguart; B Cabeza; A Gayete; M Sánchez; M I Torres; J Ferreirós
Journal:  Clin Transl Oncol       Date:  2014-11-06       Impact factor: 3.405

2.  Assessment of thoracic vasculature in patients with central bronchogenic carcinoma by unenhanced magnetic resonance angiography: comparison between 2D free-breathing TrueFISP, 2D breath-hold TrueFISP and 3D respiratory-triggered SPACE.

Authors:  Lili Wang; Peng Lv; Shuohui Yang; Mengsu Zeng; Jiang Lin
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

Review 3.  Recent technological and application developments in computed tomography and magnetic resonance imaging for improved pulmonary nodule detection and lung cancer staging.

Authors:  Jessica C Sieren; Yoshiharu Ohno; Hisanobu Koyama; Kazuro Sugimura; Geoffrey McLennan
Journal:  J Magn Reson Imaging       Date:  2010-12       Impact factor: 4.813

4.  Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment.

Authors:  Nika Guberina; Christoph Pöttgen; Martin Schuler; Maja Guberina; Georgios Stamatis; Till Plönes; Martin Metzenmacher; Dirk Theegarten; Thomas Gauler; Kaid Darwiche; Clemens Aigner; Wilfried E E Eberhardt; Martin Stuschke
Journal:  Radiat Oncol       Date:  2022-07-16       Impact factor: 4.309

Review 5.  Staging of bronchogenic carcinoma.

Authors:  S J Herman
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

6.  The clinical feasibility of using non-breath-hold real-time MR-echo imaging for the evaluation of mediastinal and chest wall tumor invasion.

Authors:  Chang Hyun Lee; Jin Mo Goo; Young Tae Kim; Hyun Ju Lee; Chang Min Park; Eun-Ah Park; Ho Yun Lee; Mi-Jin Kang; In Chan Song
Journal:  Korean J Radiol       Date:  2009-12-28       Impact factor: 3.500

Review 7.  Predicting and managing the risk of pulmonary haemorrhage in patients with NSCLC treated with bevacizumab: a consensus report from a panel of experts.

Authors:  M Reck; F Barlesi; L Crinò; C I Henschke; D Isla; S Stiebeler; D R Spigel
Journal:  Ann Oncol       Date:  2011-11-04       Impact factor: 32.976

8.  The major thoracic vascular invasion of lung cancer.

Authors:  Soichi Oka; Shuichi Shinohara; Taiji Kuwata; Masaru Takenaka; Yasuhiro Chikaishi; Ayako Hirai; Yoshinobu Ichiki; Shohei Shimajiri; Takatoshi Aoki; Fumihiro Tanaka
Journal:  Ann Med Surg (Lond)       Date:  2017-06-20

9.  SEOM-SERAM-SEMNIM guidelines on the use of functional and molecular imaging techniques in advanced non-small-cell lung cancer.

Authors:  G Fernández-Pérez; R Sánchez-Escribano; A M García-Vicente; A Luna-Alcalá; J Ceballos-Viro; R C Delgado-Bolton; J C Vilanova-Busquets; P Sánchez-Rovira; M P Fierro-Alanis; R García-Figueiras; J E Alés-Martínez
Journal:  Clin Transl Oncol       Date:  2017-12-18       Impact factor: 3.405

10.  The presurgical T staging of non-small cell lung cancer: efficacy comparison of 64-MDCT and 3.0 T MRI.

Authors:  Wei Tang; Ning Wu; Han OuYang; Yao Huang; Li Liu; Meng Li
Journal:  Cancer Imaging       Date:  2015-09-03       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.